A Multi-center, Randomized, Case-controlled, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 therapy) in COVID-19 Subjects with Acute Kidney Injury Receiving Renal Replacement Therapy
Clinical Trial Grant
Administered By
Anesthesiology, Cardiothoracic
Awarded By
Sentien Biotechnologies, Inc.
Start Date
December 7, 2020
End Date
April 29, 2022
Administered By
Anesthesiology, Cardiothoracic
Awarded By
Sentien Biotechnologies, Inc.
Start Date
December 7, 2020
End Date
April 29, 2022